Document is current
Any future updates will be listed below
-
Authors
Komai, Ali M.
Musovic, Saliha
Stenlöf, Kaj
Grote, Ludger
Zou, Ding
Hedner, Jan https://orcid.org/0000-0002-7190-394X
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 2 September 2024
Revised: 24 June 2025
Accepted: 23 July 2025
First Online: 4 September 2025
Declarations
:
: The protocol used for the completion of the current study were approved by a local independent Institutional review board (R409-97 and R268-98, Dnr 2019–05096 and Dnr 04–18) and conducted in accordance with the declaration of Helsinki and local regulations.
: N/A.
: AMK, SM, and DZ declare no conflict of interest. LG reports speaker’s bureau for ResMed Inc., Philips, Lundbeck and Astra Zeneca outside the scope of the current work. JH participated in the DSMB for Respicardia. LG and JH received unrestricted grants on behalf of the ESADA group from ResMed Inc and Philips Respironics, research grants from Bayer Pharma and Desitin GmbH. LG, KS and JH are previous part owners of two patents related to sleep apnea therapy.
